Emerson Electric Co. · EMR · Next earnings

Emerson Electric Co. reports Tuesday, Feb 2, 2027

EMR reports session not yet known with consensus EPS at $1.61 and revenue at $4.60B. Last quarter: Emerson’s FY2026 close: order growth supports a steady FY2027 outlook

Reports Session not yet known89 days awayDate unknown Industrials

What the street expects

Consensus for the coming report
Consensus EPS $1.61 Calendar consensus
Consensus revenue $4.60B Calendar consensus
Report date Feb 2, 2027 Tuesday, date unknown
Session Session not yet known 89 days away

Where EMR left off: FY2026 Q4

Full report

Emerson’s FY2026 close: order growth supports a steady FY2027 outlook

EPS surprise — Reported — vs $1.85
Revenue surprise — Reported — vs $5.11B
Stock move +2.4% Event window
Subsequent drift 0.0% Up to 20 sessions

Management maintained FY2027 guidance of approximately 5% sales growth, a 29% adjusted EBITDA margin and $7.25 EPS. It also outlined $3.8 billion of planned shareholder returns. The supplied analysis does not indicate a change to this outlook on the call.

What to watch on the call

Carried forward from the last transcript

Risks management flagged

  • Geopolitical instability in the Middle East could affect project execution.
  • Continued weakness in Europe and China may weigh on demand.
  • Material-cost inflation and potential tariff impacts could pressure performance.
  • A slowdown in the semiconductor cycle could weaken a cited growth vertical.
  • Higher-than-expected Q4 corporate expenses were a concern raised by analysts.

Questions analysts left open

  • Whether guidance is conservative enough given weakness in Europe and China.
  • Assumptions behind approximately 2% price realization and cost-inflation offsets.
  • The unexpected $45 million increase in Q4 corporate expenses.
  • The timing and composition of the order backlog, including projects extending into 2027–2028.
  • The low growth outlook for Intelligent Devices.

Ask FN2 about EMR next report

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Get the EMR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Recent EMR quarters

All EMR earnings

Sources

  1. FN2 corporate events calendar, resolved from the earnings calendar feed
  2. FN2 earnings calendar analyst consensus
  3. Earnings call transcript analysis, FY2026 Q4

Methodology

The report date comes from FN2's resolved corporate-events calendar and is marked estimated until the company confirms it. Consensus figures are the calendar's latest analyst estimates for the fiscal period and are not an FN2 forecast.

Risks and open questions are carried forward verbatim from FN2's structured analysis of the previous earnings call. Missing values stay missing and are never estimated.

By FN2 Research · Updated . For educational purposes only; not investment advice.